moxonidine has been researched along with Chronic Kidney Failure in 9 studies
moxonidine: structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "End-stage renal disease (ESRD) is characterized by markedly increased sympathetic outflow that contributes to increased cardiovascular mortality in these patients." | 2.75 | Effects of moxonidine on sympathetic nerve activity in patients with end-stage renal disease. ( Hausberg, M; Krämer, BK; Pavenstädt, H; Rump, LC; Tokmak, F, 2010) |
| "Systemic hypertension often accompanies chronic renal failure and can accelerate its progression to end-stage renal disease (ESRD)." | 2.73 | Adjunctive treatment with moxonidine versus nitrendipine for hypertensive patients with advanced renal failure: a cost-effectiveness analysis. ( Baum, D; Greiner, W; Littlewood, KJ; Zoellner, Y, 2007) |
| "3mg once daily for 7 days and both pharmacokinetic and pharmacodynamic data were determined." | 1.27 | The influence of renal function on clinical pharmacokinetics of moxonidine. ( Hutt, HJ; Kirch, W; Plänitz, V, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hausberg, M | 1 |
| Tokmak, F | 1 |
| Pavenstädt, H | 1 |
| Krämer, BK | 1 |
| Rump, LC | 3 |
| Vonend, O | 2 |
| Marsalek, P | 1 |
| Russ, H | 1 |
| Wulkow, R | 1 |
| Oberhauser, V | 1 |
| Apel, T | 1 |
| Amann, K | 3 |
| Sellin, L | 1 |
| Stegbauer, J | 1 |
| Ritz, E | 3 |
| Neumann, J | 1 |
| Ligtenberg, G | 1 |
| Oey, L | 1 |
| Koomans, HA | 1 |
| Blankestijn, PJ | 1 |
| Kotanko, P | 1 |
| Littlewood, KJ | 1 |
| Greiner, W | 1 |
| Baum, D | 1 |
| Zoellner, Y | 1 |
| Nichols, C | 2 |
| Tornig, J | 2 |
| Schwarz, U | 1 |
| Zeier, M | 2 |
| Mall, G | 2 |
| Kirch, W | 1 |
| Hutt, HJ | 1 |
| Plänitz, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Renal Denervation on Blood Pressure in Patients With Chronic Kidney Disease and Uncontrolled Hypertension[NCT04264403] | 44 participants (Actual) | Interventional | 2020-01-23 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for moxonidine and Chronic Kidney Failure
| Article | Year |
|---|---|
Cause and consequences of sympathetic hyperactivity in chronic kidney disease.
Topics: Adrenergic alpha-Agonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Arginine; Brain | 2006 |
4 trials available for moxonidine and Chronic Kidney Failure
| Article | Year |
|---|---|
Effects of moxonidine on sympathetic nerve activity in patients with end-stage renal disease.
Topics: Adult; Female; Hemodynamics; Humans; Imidazoles; Kidney Failure, Chronic; Male; Middle Aged; Renal D | 2010 |
Moxonidine treatment of hypertensive patients with advanced renal failure.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Creatinine; Disease Progression; Female; Human | 2003 |
Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated chronic renal failure.
Topics: Acrylates; Adult; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Drug Administration Sched | 2004 |
Adjunctive treatment with moxonidine versus nitrendipine for hypertensive patients with advanced renal failure: a cost-effectiveness analysis.
Topics: Antihypertensive Agents; Cost-Benefit Analysis; Disease Progression; Humans; Hypertension, Renal; Im | 2007 |
4 other studies available for moxonidine and Chronic Kidney Failure
| Article | Year |
|---|---|
Modulation of gene expression by moxonidine in rats with chronic renal failure.
Topics: Animals; Biogenic Monoamines; Disease Progression; Gene Expression Regulation; Imidazoles; Kidney Fa | 2004 |
Effect of ramipril, nifedipine, and moxonidine on glomerular morphology and podocyte structure in experimental renal failure.
Topics: Animals; Antihypertensive Agents; Capillaries; Imidazoles; Kidney Failure, Chronic; Kidney Glomerulu | 1996 |
Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure:the effects of ramipril, nifedipine and moxonidine.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta, Thoracic; Arterio | 1996 |
The influence of renal function on clinical pharmacokinetics of moxonidine.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Female; Half-Life; Humans; Imidazoles; Kidney; | 1988 |